Can a D-dimer assay, alone or combined with structured clinical risk assessment, rule out deep venous thrombosis in symptomatic patients?

West J Med. 2001 Apr;174(4):255-6. doi: 10.1136/ewjm.174.4.255.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers / analysis
  • Double-Blind Method
  • Female
  • Fibrin Fibrinogen Degradation Products / analysis*
  • Humans
  • Male
  • Mass Screening / methods
  • Middle Aged
  • Risk Assessment
  • Sensitivity and Specificity
  • Ultrasonography, Doppler / methods*
  • Venous Thrombosis / diagnosis*
  • Venous Thrombosis / epidemiology

Substances

  • Biomarkers
  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D